Diabetic cardiovascular autonomic neuropathy: Risk factors, clinical impact and early diagnosis;Neuropatia autonômica cardiovascular diabética: Fatores de risco, impacto clínico e diagnóstico precoce

Arquivos Brasileiros de Cardiologia

Volumn 90, Issue 4, 2008, Pages

  Rolim, Luiz Clemente De Souza Pereira ^a,b   De Sá, João Roberto ^a   Chacra, Antonio Roberto ^a   Dib, Sérgio Atala ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Autonomic nervous system; Cardiovascular diseases; Diabetes mellitus; Heart rate variability; Mortality; Risk factors

Indexed keywords

AUTONOMIC NEUROPATHY; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIABETIC PATIENT; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SYMPTOMATOLOGY;

EID: 44849090145     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000400014     Document Type: Review

References (74)

1. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-97.
2. Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev. 1999; 7: 300-15.
3. Low PA, Vernino S, Suarez G Autonomic dysfunction in peripheral nerve disease. Muscle Nerve. 2003; 27: 646-61.
4. Dyck PJB, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 1999; 53: 2113-21.
5. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. QJ Med. 1980; 49: 95-108.
6. Ziegler D, Piolot R. Prevention of diabetic neuropathy by near-normoglycemia: a 12-year prospective study from the diagnosis of IDDM (Abstract). Diabetes. 1998; 47 (Suppl.1): A63.
7. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. QJ Med. 1990; 75: 635-46.
8. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003; 26: 1553-79.
9. Cellek S. Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications. Curr Pharm Des. 2004; 10: 3683-95.
10. Schnell O, Kiline S, Rambeck A, Standl E. Insulin therapy improves cardiac autonomic function in type 2 diabetic patients. Herz. 2004; 29: 519-23.
11. Tesfaye S, Chatuverdi N, Eaton SEM, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005; 352: 341-50.
12. Colhoun HM, Francis DP, Rubens MB, Underwood SR. The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification. Diabetes Care. 2001; 24: 1108-14.
13. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999; 353: 617-22.
14. Gaede P , Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-93.
15. Orchard TJ, Olson JC, Erbey JR, Williams K. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. Diabetes Care. 2003; 26: 1374-9.
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998; 41: 416-23.
17. Rolim LCSP, Chacra AR, Dib SA. Diabetic neuropathies heterogeneity in type 1 and type 2 diabetes mellitus with the same pattern of glycemic control. Diabetes. 2006; 55: A508.
18. Smulders YM, Jager A, Gerritsen J, Dekker J, Nijpels G, Heine R, et al. Cardiovascular autonomic function is associated with (micro-) albuminuria in elderly caucasian subjects with impaired clucose tolerance or Type 2 Diabetes. Diabetes Care. 2000; 23: 1369-74.
19. Valensi P, Paries J, Lormeau B, Assad N, Attali JR. Cardiac parasympathetic changes: a new component of the insulin resistance syndrome. Diabetes 1999; 48 (Suppl.1):A149.
20. Vinik AI, Erbas T, Park TS, Stansberry KB, Scanelli JA, Pittenger GL. Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care. 2001; 24: 1468-75.
21. Vinik AI, Anandacoomaraswamy D, Ullal J. Antibodies to neuronal structures: innocent bystanders or neurotoxins? Diabetes Care. 2005; 28: 2067-72.
22. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies. Diabetes Care. 2005; 28: 956-62.
23. Task Force of the European Society of Cardiology and the American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996; 93: 1043-65.
24. Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, et al. KORA study Group. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006; 114: 153-9.
25. Moran A, Palmas W, Field L, Bhattarai J, Schwartz JE, Weinstock RS, et al. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care. 2004; 27: 972-7.
26. Witte DR, Tesfaye S, Chaturvedi N, Eaton Se, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005; 48: 164-71.
27. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol. 1999; 84: 687-91.
28. Makimattila S, Schlenzka A, Mantysaari M, Bergholm R, Summanen P, Saar P, et al. Predictors of abnormal cardiovascular autonomic function measured by frequency domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care. 2000; 23: 1686-93.
29. Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MIJ. Ocurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-yer follow-up from the diagnosis. Diabetes. 1996; 45: 308-15.
30. Töyry JP, Niskanen LK, Mäntisaari MJ, Länsimies EA, Uusitupa MIJ. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1996; 27: 1316-8.
31. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev. 2004; 20: 268-87.
32. Hasslacher C, Bässler G. Prognose der kardialen autonomen Neurophatie bei Diabetikern. Müch Med Wochenschr. 1983; 125: 375-7.
33. Navarro X, Kennedy WR, Loewenson RB, Sutherland DER. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes. Diabetes. 1990; 39: 802-6.
34. O'Brien IA, McFadden JP, Corral RJM. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. QJ Med. 1991; 79: 495-502.
35. Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991; 34: 182-5.
36. Jermendy G, Toth L, Vörös P, Koltai MZ, Pogatsa G. Cardiac autonomic neuropathy and QT interval length: a follow-up study in diabetic patients. Acta Cardiol. 1991; 46: 189-200.
37. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med. 1993; 10: 820-4.
38. Luft D, Rak R, Renn W, Konz K, Eggstein M. Diabetische autonome Neuropathie: Verlauf und prognostische Bedeutung Kardiovaskulärer Reflexteste. Diab Stoffw. 1993; 2: 239-44.
39. Navarro X, Kennedy WR, Aeppli D, Sutherland DER. Neuropathy and mortality in diabetes: influence of pancreas transplatation. Muscle Nerve. 1996; 19: 1009-16.
40. Orchard TJ, Lloyd CE, Maser RE, Kuller LH. Why does diabetic autonomic neuropathypredict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract. 1996; 34 (Suppl): S165-S171.
41. Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in tipe 1 diabetic patients: a 5 year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study Diabetes, Piemonte Affiliate. Diabetes Care. 2000; 23: 1381-3.
42. Maser RE, Mitchell BD, Vinik AL, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003; 26: 1895-901.
43. Rolim LCSP, Rezende P, Sá JR, Dib AS. Cardiovascular autonomic neuropathy is associated with coronary artery calcification in type 2 diabetic patients. Diabetes. 2004; 53 (Suppl.2): A186.
44. Wheeler S, Ahroni J, Boyko E. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract. 2002; 58: 131.
45. Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet. 1992; 339: 1462-4.
46. Harris ND, Heller SR. Sudden death in young patients with type 1 diabetes: a consequence of disease, treatment or both? Diabet Med. 1999; 16: 623-5.
47. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Costas T, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000; 283: 3223-9.
48. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial isquemia. Diabetes Care. 2001; 24: 339-43.
49. Beck MO, Silveiro SP, Friedman R, Clausell N, Gross JL. Asymptomatic coronary artery disease is associated with cardiovascular autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care. 1999; 22: 1745-7.
50. Rolim LCSP, Rezende PH, Sá JR, Nasri F, Meneghello R, Chacra AR, et al. Coronary calcification score is higher in type 2 diabetic patients with cardiovascular autonomic neuropathy. Sao Paulo Med J. 2007; 125: 126-7.
51. Lee KH, Jang HJ, Kim YH, Lee EJ, Choe YS, Choi Y, et al. Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease. Am J Cardiol. 2003; 15: 1458-61.
52. Sozzi FB, Elhendy A, Rizzello V, Biagini E, van Domburg RT, Schinkel AF, et al. Prognostic significance of myocardial ischemia during dobutamine stress echocardiography in asymptomatic patients with diabetes mellitus and no prior history of coronary events. Am J Cardiol. 2007; 99: 1193-5.
53. Airaksinen KEJ. Silent coronary disease in diabetes - a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia. 2001; 44: 259-66.
54. Huikuri HV, Jokinen V, Syvänne M, Nieminen MS, Airaksinen KEJ, Ikäheimo MJ, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1999; 19: 1979-85.
55. Kacem K, Sercombe C, Hammami M, Vicaut E, Sercombe R. Sympathectomy causes aggravated lesions and dedifferentiation in large rabbit atherosclerotic arteries without involving nitric oxide. J Vasc Res. 2006; 43: 289-305.
56. Wackers FJT, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barret EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects. The DIAD study. Diabetes Care. 2004; 27: 1954-61.
57. Wackers FJT, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, et al. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes mellitus in the DIAD study. Diabetes Care. 2007; (in press).
58. Monteagudo PT, Moisés VA, Kohlmann O, Ribeiro AB, Lima VC, Zanella MT. Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin Cardiol. 2000; 23: 371-5.
59. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002; 347: 797-805.
60. American Diabetes Association and American Academy of Neurology: Consensus Statement. Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care. 1988; 11: 592-7.
61. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy: autonomic nervous system testing. Diabetes Care. 1992; 15 (Suppl. 3): 1095-103.
62. Ewing DJ, Campbell IW, Burt AA, Clarke BF. Vascular reflexes in diabetic autonomic neuropathy. Lancet. 1973; 2: 1354-6.
63. Howorka K, Pumprla J, Schabmann A. Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Aut Nerv Syst. 1998; 69: 164-72.
64. Chessa M, Butera G, Lanza GA, Bossone E, Delogu A, Rosa GD, et al. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children. Herz. 2002; 27: 785-90.
65. Malliani A, Pagani M, Lombardi F, Cerutti MS. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991; 84: 482-90.
66. Schroeder EB, Chambless LE, Duanping L, Prineas RJ, Evans GW, Rosamond WD, et al. Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2005; 28: 668-74.
67. Nesto RW. Screening for asymptomatic coronary artery disease in diabetes. [Editorial]. Diabetes Care. 1999; 22: 1393.
68. Sima AAF. Does insulin play a role in cardiovascular autonomic regulation? Diabetes Care. 2000; 6: 724-5.
69. Lindmark S, Wiklund U, Bjerle P, Eriksson JW. Does the autonomic nervous system play a role in the development of insulin resistence? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects. Diabet Med. 2003; 20: 399-405.
70. Burger AJ, Weinrauch LA, D'Elia JA Aronson D. Effect of glycemic control on heart rate variability in type 1 diabetic patients with cardiac autonomic neuropathy. Am J Cardiol. 1999; 84: 687-91.
71. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2006; 2: 334-9.
72. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care. 1993; 16: 773-9.
73. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005; 90: 5896-903.
74. Kempler P. Autonomic neuropathy: a marker of cardiovascular risk. Br J Diabetes Vasc Dis. 2003; 3: 84-9.